| Nov 22 |
Aclaris Therapeutics And 2 Other US Penny Stocks To Watch
|
| Nov 20 |
Aclaris upgraded to overweight by Cantor on in-licensing deal
|
| Nov 20 |
Aclaris Therapeutics upgraded to Buy from Hold at Jefferies
|
| Nov 20 |
Aclaris Therapeutics upgraded to Buy from Neutral at BTIG
|
| Nov 19 |
Aclaris Stock Soars As Analysts See Fresh Momentum After Strategic Review And Encouraging Promising Pipeline Developments
|
| Nov 19 |
Aclaris stock soars for second day on licensing deal, analyst upgrades
|
| Nov 19 |
Aclaris Therapeutics secures global rights to Biosion’s antibodies
|
| Nov 19 |
ACRS Stock Up on Licensing Deal With Biosion for Two Immunology Drugs
|
| Nov 18 |
Aclaris stock rallies 53% amid licensing deal, Piper upgrade
|
| Nov 18 |
Aclaris signs license deal for biologics assets
|
